Cited by 696Cancer survivorship and careCancer-related cognitive impairment studiesHealth Systems, Economic Evaluations, Quality of Life

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-prostate instrument

Esper, Peg, Mo, Fei, Chodak, Gerald, Sinner, Michael, Cella, David, Pienta, Kenneth J.·1997·Urology

DOI 10.1016/s0090-4295(97)00459-7

Open this paper in CoChat — free account

Abstract

Objectives As the incidence of prostate cancer in the United States exceeds 330,000 in 1997, increasingly more men are faced with treatment choices for which there is no clear approach. At every stage of disease, these treatment choices may involve clinically equivalent modalities that differ in side effects and impact upon quality of life (QOL). Comprehensive, yet efficient, questionnaires are needed to measure QOL in patients with prostate cancer.Methods Developed as a disease-specific adjunct to the Functional Assessment of Cancer Therapy (FACT) measurement system, a 12-item prostate cancer subscale (PCS) was developed and tested in three independent samples: a subscale development sample (n = 43), validity sample 1 (n = 34), and validity sample 2 (n = 96). The 12 items ask about symptoms and problems specific to prostate cancer. These questions are added to the general (FACT-G) instrument, thereby comprising a 47-item questionnaire.Results Internal consistency of the PCS ranged from 0.65 to 0.69, with coefficients for FACT-G subscales and aggregated scores ranging from 0.61 to 0.90. Concurrent validity was confirmed by the ability to discriminate patients by disease stage, performance status, and baseline prostate-specific antigen (PSA) level. Sensitivity to change in performance status and PSA score over a 2-month period suggested that some subscales of the FACT-Prostate (P) (including the PCS) are sensitive to meaningful clinical change.Conclusions Our findings support use of the FACT-P as a meaningful component of QOL evaluation in men undergoing therapy for prostate cancer.

Integrity signals

Registry

Crossref · 10.1016/s0090-4295(97)00459-7

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
Self-citation
Cancer statistics, 1997
Parker, S. L., Tong, T., Bolden, S., & Wingo, P. A. (1997) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.47.1.5 · Cited by 2,000
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
Tannock, I. F., Osoba, D., Stockler, M. R., Ernst, D. S., Neville, A. J., Moore, M. J., Armitage, G. R., Wilson, J. J., Venner, P. M., Coppin, C., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.6.1756 · Cited by 1,575
Quality-of-life outcomes in men treated for localized prostate cancer
Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., Leach, G. E., & Brook, R. H. (1995) · JAMA · doi:10.1001/jama.1995.03520260051032 · Cited by 1,020
Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrument
Cella, D. F., Bonomi, A. E., Lloyd, S. R., Tulsky, D. S., Kaplan, E. J., & Bonomi, P. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)00450-f · Cited by 750
Self-citation
Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response.
Tannock, I. F., Gospodarowicz, M., Meakin, W., Panzarella, T., Stewart, L., & Rider, W. D. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.5.590 · Cited by 407
Quality-of-life outcomes in men treated for localized prostate cancer
Litwin, M. S. (1995) · JAMA · doi:10.1001/jama.273.2.129 · Cited by 281
The association of benign prostatic hyperplasia and cancer of the prostate
Bostwick, D. G., Cooner, W. H., Denis, L., Jones, G. W., Scardino, P. T., & Murphy, G. P. (1992) · Cancer · doi:10.1002/1097-0142(19920701)70:1+ · Cited by 222
Early Detection of Prostate Cancer
Scardino, P. T. (1989) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)01800-0 · Cited by 210
Quality of Life and Functional Status Measures in Patients With Head and Neck Cancer
DʼAntonio, L. L., Zimmerman, G. J., Cella, D. F., & Long, S. A. (1996) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1996.01890170018005 · Cited by 197
Self-citation

Show all 22 references

Research works printed but not linked: 2

da Silva, 1993, Quality of life in patients with prostatic cancer. A feasibility study, Cancer, 71, 1138, 10.1002/1097-0142(19930201)71:3+<1138::AID-CNCR2820711436>3.0.CO;2-7 · DOI
Esper, 1995, FACT-P: a new instrument for quality of life evaluation in prostate cancer (abstract), J Urol, 153

Sorted by citations

Items 601–696 of 696

The Influence of Stigma on Quality of Life and Relationship Satisfaction for Prostate Cancer Survivors and Their Partners
Wood, A. W. (2015) · Journal of International Crisis and Risk Communication Research · Cited by 1
Health-related Quality of Life in Intermediate- or High-risk Patients Treated With Radical External Radiotherapy and Adjuvant Docetaxel for Localized Prostate Cancer: A Randomized, Phase III SPCG-13 Study
Lehtonen, M., Sormunen, J., Hjälm-Eriksson, M., Karlsson, C. T., Huttunen, T., Ginman, C., Kellokumpu‐Lehtinen, P., & On Behalf of the Investigators of the Scandinavian Prostate Cancer Group Study No 13 (2021) · Anticancer Research · doi:10.21873/anticanres.15460 · Cited by 1
Quality of Life
Siembida, E. J., & Salsman, J. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-85702-8_24 · Cited by 1
Quality of Life
Salsman, J. M., Pearman, T. P., & Cella, D. F. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4866-2_15 · Cited by 1
Self-citation
The effects of pharmacist interventions on health outcomes in patients with advanced prostate cancer in Brazil
Aguiar, P. M., Mori, A. L. P. M., de Lima, M. G., Rossi, M. D. S. P. N., Nicoletti, M. A., Martins, K. O., Lopes, A. L. D. A., Coan, T. C. M., Fugita, O. E. H., & Storpirtis, S. (2022) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902021000219273 · Cited by 2
Efficacy and Safety of Brazilian Green Propolis in Biochemically Recurrent Prostate Cancer after Radical Prostatectomy: A Single-Arm Phase II Study
Goto, T., Kimura, H. M., Yoshino, T., Sawada, A., Akamatsu, S., Kobayashi, T., Yamasaki, T., Tazawa, S., Fujimoto, M., Hidaka, Y., et al. (2022) · International Journal of Translational Medicine · doi:10.3390/ijtm2040047 · Cited by 1
COmparing Urolift and Standard Transurethral resection of prostate Ahead of Radiotherapy in men with urinary symptoms secondary to prostate enlargement in Southwest London and North Cumbria (CO-STAR): a study protocol for a randomised feasibility study
Wong, K. A., Kinsella, N., Seth, J. H., Nicol, D. L., Cahill, D. J., Kasivisvanathan, R., Withington, J., Moghul, M. R., Moss, C. L., Hemelrijck, M. V., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-076621 · Cited by 1
Comparing Efficacies of Different Exercises on Androgen Deprivation Therapy Adverse Effects in Prostate Cancer Patients: A Network Meta-Analysis
Hu, S., Xiong, X., Qiu, S., Li, J., Xu, H., Zhou, X., Wang, S., Wei, Q., & Yang, L. (2024) · Urologia Internationalis · doi:10.1159/000538114 · Cited by 1
“Higher FACT-P score indicated better QoL [16].”
Comparison of quality of life after radical treatment in prostate cancer: radical prostatectomy versus external radiotherapy
Hernández-Flores, C. N., Artiles-Hernández, J. L., Armas-Molina, J. V., Vera-Álamo, L., & León-Medina, P. (2024) · Cirugía y Cirujanos (English Edition) · doi:10.24875/cirue.m23000633 · Cited by 1
Decision regret in older men with metastatic castration-resistant prostate cancer and associations with treatment received and baseline variables
Guo, S., Timilshina, N., Kim, V. S., Emmenegger, U., & Alibhai, S. M. H. (2025) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2025.102240 · Cited by 1
Impact of Enhanced Recovery After Surgery Protocol on Perioperative Quality of Life in Robot‐Assisted Radical Prostatectomy: A Single‐Center Prospective Cohort Study
Nakamura, M., Muraki, Y., Yamada, Y., Matsumoto, S., Tsuji, Y., Tsuru, I., Ono, A., Watanabe, J. A., Okabe, K., Kashiwagi, M., et al. (2025) · International Journal of Urology · doi:10.1111/iju.70177 · Cited by 1
“To assess the quality of life of patients undergoing RARP, the Functional Assessment of Cancer Therapy-Prostate (FACT-P) was administered 1 day before and 1 month after surgery [16].”
Health-Related Quality of Life Issues
Wei, J. T., & Miller, D. C. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-776-5_19 · Cited by 1
Late Toxicity and Quality of Life
Geier, M., & Geinitz, H. (2014) · Medical radiology · doi:10.1007/174_2014_1035 · Cited by 1
“The FACT-G instrument also can be enhanced using the disease-specific FACT-Prostate (FACT-P) modifier (Esper et al. 1997).”
Method
Quality of Life: Impact of Prostate Cancer and its Treatment
Salami, S. S., & Kavoussi, L. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800077-9.00061-x · Cited by 1
Quality of Life: Impact of Prostate Cancer and its Treatment
Davis, J. W., & Schellhammer, P. F. (2003) · Elsevier eBooks · doi:10.1016/b978-012286981-5/50052-5 · Cited by 1
The Role of a Standardized Clinical Care Pathway in Patient Satisfaction and Quality of Life Outcomes after Robotic Assisted Laparoscopic Radical Prostatectomy
Turini, G. A., Clark, M. A., Machan, J. T., Tucci, C. T., & Renzulli, J. (2016) · Urology Practice · doi:10.1016/j.urpr.2016.06.006 · Cited by 1
Values in Behavioral Medicine
Davison, G. C., & Feng, M. C. (2018) · Springer eBooks · doi:10.1007/978-0-387-93826-4_35 · Cited by 1
Propiedades psicométricas de la Escala de Evaluación Funcional para el Tratamiento del Cáncer, versión próstata (FACT-P), en pacientes mexicanos
Lerma, A., Meneses-García, A. A., Sánchez-Rodríguez, J. J., Bello, M. E., Jiménez-Ríos, M. Á., Santos, N. A. A., & Vazquez, O. (2020) · Cirugía y Cirujanos · doi:10.24875/ciru.19001755 · Cited by 1
Couples with Infertility: The Influence of Quality of Life, Relationship Satisfaction, Resilience, Depression, and Shame
Wilson, N. (2021) · Journal of International Crisis and Risk Communication Research · Cited by 1
Calidad de vida en pacientes con cáncer de próstata, operados de prostatectomía radical laparoscópica
VIVEROS-CONTRERAS, K. L. S.-G. C. (2014) · Revista Mexicana de Urología · doi:10.48193/revistamexicanadeurologa.v74i3.172 · Cited by 1
Patient-Clinician Choice in Palliation of Metastatic Prostate Cancer
Kaisary, A. V. (2000) · Drugs & Aging · doi:10.2165/00002512-200017050-00001 · Cited by 1
“[48-61] These include generic, cancer-specific and prostate cancer-specific evaluation tools.”
Background
Contemporary measures for the assessment of health-related quality of life in prostate cancer
Wei, J. T. (2001) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.1.2.205 · Cited by 1
Pilot Study of Oral Eniluracil/5‐FU in the Palliation of Hormone‐Refractory Prostate Cancer
Rosenthal, M. A., Thomas, D. M., Davis, I. D., Toner, G. C., Noordin, N., & Zalcberg, J. R. (2001) · The Prostate Journal · doi:10.1046/j.1525-1411.2001.003001030.x · Cited by 1
COMPARING THE RESPONSIVENESS OF TWO HEALTH-RELATED QUALITY OF LIFE INSTRUMENTS IN A PHASE III RANDOMIZED CLINICAL TRIAL OF MEN WITH PROSTATE CANCER (NCIC CTG PR.3): THE EORTC QLQ-C30+3 WITH PR17 TRIAL SPECIFIC CHECKLIST VERSUS THE FACT-P
Murray, Y. (2015) · QSpace (Queen's University Library) · Cited by 1
ARTICLES Quality of Life in Advanced Prostate Cancer: Results of a Randomized Therapeutic Trial
Moinpour, C. M., Savage, M. J., Troxel, A. B., Lovato, L., Eisenberger, M. A., Veith, R. W., Higgins, B., Yee, M., Blumenstein, B. A., Crawford, E. D., et al. (2013) · Cited by 1
Análisis en una serie de vigilancia activa. Factores relacionados con la evolución, la calidad de vida y la ansiedad
Asensio, S. M. (2021) · doi:10.14201/gredos.145782 · Cited by 1
Health Outcomes of Sexual and Gender Minorities After Cancer: A Scoping ReviewPreprint
Pratt‐Chapman, M. L., Rodríguez-Díaz, C. E., & Alpert, A. B. (2020) · doi:10.21203/rs.3.rs-88539/v1 · Cited by 1
New Paradigms in the Management of Hormone Refractory Disease
Kamradt, J. M., & Pienta, K. J. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-714-7_16
Self-citation
Quality of Life of Patients with Ovarian Cancer
Chie, W., & Greimel, E. (2012) · InTech eBooks · doi:10.5772/27298
High dose rate brachytherapy boost for localized prostate cancer Clinical and patient-reported outcomes
Wahlgren, T. (2006) · Figshare
The effect of exercise intensity on physiological and psychological outcomes in breast and prostate cancer survivors: a controlled study
Martin, E. (2014) · ResearchOnline@ND (The University of Notre Dame)
Krankheitsspezifische Belastungen von Tumorpatienten in der Strahlentherapie
Firsching, M. (2002) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.668
Estudio de la estructura factorial de la escala de calidad de vida FACIT-P para los pacientes con cáncer de próstata
Ballesteros, M., Sánchez, R., Merchán, B., & Varela, R. (2012) · Revista Colombiana de Cancerología · doi:10.1016/s0123-9015(12)70013-6
Re: Aflibercept versus Placebo in Combination with Docetaxel and Prednisone for Treatment of Men with Metastatic Castration-Resistant Prostate Cancer (VENICE): A Phase 3, Double-Blind Randomised Trial
Taneja, S. S. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.11.086
Highlights from the 40th Annual Meeting of the American Society of Clinical Oncology New Orleans, LA June 2004
Lee, D. M., Price, N., Reddy, G. K., Sartor, O. A., & Jain, V. K. (2004) · Clinical Prostate Cancer · doi:10.1016/s1540-0352(11)70064-6
CLINICAL CONDUCT AND NURSING QUALITY OF LIFE IN PROSTATE CANCER
Sinibaldi, V. J., & Arzoomanian, R. Z. (2001) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70233-1
Métastases osseuses : bonnes pratiques éthiques et cliniques en physiothérapie
Grégoire, S., Lacoursière, M., & Kwan, J. L. (2013) · Papyrus : Institutional Repository (Université de Montréal)
Quality of Life with Localized Prostate Cancer: Japanese Perspectives
Namiki, S., Kwan, L. C., & Arai, Y. (2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_166
Leveraging Outcomes Research to Optimize Prostate Cancer Care
O'Neil, B. B., & Resnick, M. J. (2015) · Urology Practice · doi:10.1016/j.urpr.2015.04.001
Summary and Future Directions
Barofsky, I. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9819-4_12
THE PHYSIOLOGICAL AND PSYCHOSOCIAL EFFECTS OF A 16-WEEK COMBINED AEROBIC AND RESISTANCE EXERCISE PROGRAM IN MEN RECEIVING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER
Murphy, R. M. (2011) · Library and Archives Canada (Government of Canada)
Estudo randomizado testando musicoterapia na redução da fadiga relacionada ao câncer em mulheres com neoplasia maligna de mama ou ginecológica em curso de radioterapia
Alcântara-Silva, T. R. D. M. (2012)
167 Quality of Life in Men Undergoing Radical Prostatectomy for Prostate
Wallen, E., & Pruthi, R. S. (2010)
Efecto precoz de la deprivación androgénica sobre la sarcopenia. Valoración de la masa muscular mediante TC y DEXA
Vallejo, B., & Juan, E. S. (2012) · TDX (Tesis Doctorals en Xarxa)
The Feasibility and Efficacy of Prehabilitation for Prostate Cancer Surgery
Hilton, W. J. (2016) · The Atrium (University of Guelph)
Design and Validation of the Marmara Post-prostatectomy Incontinence Symptom Score
Akgül, M., Sulukaya, M., Şahan, A., Bekiroğlu, N., Tınay, İ., Türkeri, L., & Tarcan, T. (2017) · Journal of Urological Surgery · doi:10.4274/jus.1097
“There are 4 questionnaires, which are validated, investigating incontinence and impotence after RP (7,8,9,10).”
Background
Patient-reported outcome measures for adverse events: A systematic review and COSMIN evaluation study
Hancock, M. (2017) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r34q7r41c
A lifestyle intervention to improve outcomes in men with castrate-resistant prostate cancer
Greasley, R. (2018) · Sheffield Hallam University · doi:10.7190/shu-thesis-00165
Determinants Associated with Participation in Physical Activity Among Patients with Prostate CancerPreprint
Kim, S., Nam, K. E., Park, Y. H., Lee, J. Y., & Lee, J. I. (2021) · Research Square · doi:10.21203/rs.3.rs-681692/v1
Validação da versão brasileira do Functional Assessment of Cancer Therapy-Prostate (FACT-P, versão 4) em homens com câncer de próstata não metastático
de Held, P. A. (2018) · doi:10.47749/t/unicamp.2018.1079698
Faculty Opinions recommendation of Abiraterone and increased survival in metastatic prostate cancer.
Poppel, H. V., & Tolkach, Y. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.11812958.15779296
Design and Analysis of Quality of Life Data
Moinpour, C. M., & Troxel, A. B. (2005) · Chapman & Hall/CRC eBooks · doi:10.1201/9781420027761.ch15
Introduction
Omlin, A. G., Pezaro, C. J., & Bono, J. S. D. (2014) · Current clinical urology · doi:10.1007/978-1-4939-1176-9_12
Prostate Cancer Clinical Trials Group - The University of Michigan Site
Hussain, M. (2014) · Defense Technical Information Center (DTIC) · doi:10.21236/ada612883
Outcomes Research
Litwin, M. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00005-0
Quality of Life in Men Undergoing Radical Prostatectomy for Prostate Cancer
Pearson, M., Wallen, E., & Pruthi, R. S. (2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_167
QUALITY OF LIFE IN METASTATIC PROSTATE CANCER AMONG MEN OF LOWER SOCIOECONOMIC STATUS
Knight, S. J., Chmiel, J. S., Kuzel, T. M., Sharp, L. K., ALBERS, M., FINE, R., Moran, E. M., Nadler, R. B., Sharifi, R., & Bennett, C. L. (1998) · The Journal of Urology · doi:10.1097/00005392-199811000-00041
Ultrasonidos focalizados de alta intensidad (HIFU) en tumores prostáticos órgano-confinados
Márquez, J. M. M., Baños‐Álvarez, E., Isabel‐Gómez, R., & Blasco‐Amaro, J. A. (2022) · AETSA Área de Evaluación de Tecnologías Sanitarias de Andalucía, Fundación Progreso y salud. Consejería de Salud y Familias. Junta de Andalucía eBooks · doi:10.52766/gofx3841
Evaluation of the Effect of Prognostic Variables on the Survival Analysis of Prostate Cancer
Sourav, S. H., & Tamanna, R. J. (2022) · Biometrical Letters · doi:10.2478/bile-2022-0007
Análisis comparativo y evolutivo de la prostatectomía radical en la última década. Impacto de la implantación de la cirugía robótica en un único centro español
Garcia-Cortes, A. (2022) · doi:10.15581/10171/65758
Psychometric properties of the Functional Assessment of Cancer Therapy, prostate version (FACT-P), in Mexican patients
Lerma, A., Meneses-García, A. A., Sánchez-Rodríguez, J. J., Bello, M. E., Jiménez-Ríos, M. Á., Santos, N. A. A., & Galindo-Vázquez, Ó. (2023) · Cirugía y Cirujanos (English Edition) · doi:10.24875/cirue.m22000190
Quality of Life in Patients and Their Spouses and Cohabitating Partners in the Year Following a Cancer Biopsy (the Couples Cope Study): Protocol for a Prospective Observational Study
Moreno, P. I., Worch, S., Thomas, J. L., Nguyen, R. L., Medina, H. N., Penedo, F. J., Moskowitz, J. T., Yanez, B. R., Kircher, S. M., KUNDU, S. D., et al. (2024) · JMIR Research Protocols · doi:10.2196/52361
Military service and health-related quality of life among gay and bisexual prostate cancer survivors: Results from the Restore-2 study
Bates, A. J., Mitteldorf, D., Rosser, B. R. S., Wheldon, C. W., Polter, E. J., Ross, M. W., Talley, K. M., Haggart, R. C., Wright, M. M., West, W. G., et al. (2024) · BMJ Military Health · doi:10.1136/military-2023-002649
Coping Mechanisms and Illness Perception Associated with Health-Related Quality of Life of Prostate Cancer Patients in Ogun State
Olorunniyi, S. B., Olanrewaju, M., & N., O. C. (2024) · African Journal of Biology and Medical Research · doi:10.52589/ajbmr-u7oftnm3
Niraparib and Abiraterone Acetate (Akeega)
CADTH (2024) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2024.879
Comparación de la calidad de vida tras el tratamiento radical en cáncer de próstata: prostatectomía radical frente a radioterapia externa
Flores, C. N. H., Hernández, J. L. A., Armas-Molina, J. V., Vera-Álamo, L., & León-Medina, P. (2024) · Cirugía y Cirujanos · doi:10.24875/ciru.22000249
Cultural Adaptation and Validation of the Punjabi Version of EPIC
Lee, T. K., Kwan, W., & Singh‐Carlson, S. (2024) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2024.25.6.1945
Quality of life for androgen receptor targeted agents in patients with metastatic castration resistant prostate cancer
KUZMA, M., Nekvindová, L., & Kliment, J. (2024) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2024_89
Questionnaires and PROs for Urinary, Bowel, and Erectile Dysfunction After a Radical Prostatectomy
Nunzio, C. D., Tema, G., Ghezzo, N., Testa, A., Deanesi, N., Raso, G., & Esperto, F. (2024) · Urodynamics, neurourology and pelvic floor dysfunctions · doi:10.1007/978-3-031-76341-0_11
Lessons in complexity learned during a Canadian virtual pragmatic trial for prostate cancer survivorship
Pfisterer, K. J., Young, K., Lohani, R., Xiong, T., Anandarajan, T., Ng, D., Jiao, T., Nunn, C., Bryant‐Lukosius, D., Rendon, R., et al. (2025) · Cancer Survivorship Research & Care · doi:10.1080/28352610.2025.2474592
The Impact of Prostate Cancer on the Quality of Life of Men Attending Urology Clinic in a Tertiary Teaching Hospital
Osonuga, A., Ubani, C., Osonuga, A., Osonuga, O., Okoye, G. C., & Osonuga, A. C. (2025) · African Journal of Biology and Medical Research · doi:10.52589/ajbmr-sm4sgeib
Process evaluation for the STAMINA randomised controlled trial: A protocol
Ibeggazene, S., Reale, S., Scope, A., Price, G., Sutton, E., Bourke, L., Collinson, M., Stokes, J. R., Steed, L., Rosario, D. J., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0323275
“We hypothesise that the intervention will improve disease-specific quality of life and/or reduce fatigue after 12 months (FACT-Prostate [10] & FACIT-Fatigue [11] questionnaires, respectively).”
Feasibility of Wave Health to monitor electronic patient-reported outcomes (ePROs) in prostate cancer patients
Mediavilla, B. G., Congregado, B., Espinos, E. L., BELENCHON, I. R., Basterretxea, L., Sancho, G., Laínez, N., Büchser, D., Leturgez, T., Schmitz, A., et al. (2025) · ESMO Real World Data and Digital Oncology · doi:10.1016/j.esmorw.2025.100177
Development and Validation of the PREVES-HOR Questionnaire: A Patient-Reported Measure of Hormone Therapy-Related Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
Lorenzo, G. D., Verde, A., Scafuri, L., Baio, R., Grillone, F., Passaro, F., Crocetto, F., Bruzzese, D., Ferraioli, A., Monteleone, E., et al. (2025) · Oncology · doi:10.1159/000548317
“…sexual function, and some treatment side effects, but it does not explicitly probe many hallmark ADT toxicities (e.g., hot flashes or body feminization), and its overall reliability for prostate-specific concerns has been reported as only marginal (Cronbach’s α near the minimum acceptable) [13].”
Impact of Prolonged Catheterization for Vesicourethral Leakage on Continence and Quality of Life After Robotic Prostatectomy
Taniguchi, H., Ikeda, J., Inoue, M., Masuo, Y., & Kinoshita, H. (2025) · Cureus · doi:10.7759/cureus.99332
“QoL was evaluated using validated instruments, including the Functional Assessment of Cancer Therapy-General (FACT-G) [10], prostate cancer-specific module (FACT-P) [11], and urinary subscales of the EPIC questionnaire [9].”
Does strength training improve musculoskeletal health and body composition in black men with prostate cancer on androgen deprivation therapy
Hanson, E. D. (2011) · University Libraries (University of Maryland)
Additional file 1 of Acupuncture versus sham acupuncture and usual care for Antiandrogen-Induced hot fLashes in prostate cancer (AVAIL): study protocol for a randomized clinical trial
Qin, Z., Zang, Z., Yu, J., Lv, J., Li, N., Zhang, J., Yang, M., Kwong, J. S. W., Pang, R., Wang, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26633208
Additional file 1 of Supported exercise TrAining for Men wIth prostate caNcer on Androgen deprivation therapy (STAMINA): study protocol for a randomised controlled trial of the clinical and cost-effectiveness of the STAMINA lifestyle intervention compared with optimised usual care, including internal pilot and parallel process evaluation
McNaught, E., Reale, S., Bourke, L., Brown, J. E., Collinson, M., Day, F., Hewison, J., Farrin, A. J., Ibeggazene, S., Innes, A. Q., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25596471
Additional file 1 of Examining the influence of illness perception and financial toxicity on the quality of life of prostate cancer patients
Akin‐Odanye, E. O., Ogo, C. N., Sulaiman, F. A., Suleiman, L., Ogunsanya, M. E., & Odedina, F. T. (2021) · Figshare · doi:10.6084/m9.figshare.14633975
The Role of Signs or Symptoms
Barofsky, I. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9819-4_5
A Longitudinal Study on Development and Validation of the Prostate Cancer Scale Among the System of Quality of Life Instruments for Patients with Cancer (QLICP-PR V2.0) Based on Classical Test Theory and Generalizability Theory
Wei, W., Guo, F., Zhang, T., Chen, Y., Li, G., Luo, J., & Wan, C. (2026) · Annals of Surgical Oncology · doi:10.1245/s10434-025-19044-4
Comparison of the EORTC QLQ PR25 and the FACT-P for assessing quality of life in patients with prostate cancer – an updated literature review
Chen, D. J., Jomy, J., Ning, T., Cheng, S., Khan, M., Bottomley, A., Cella, D. F., Chung, H., Lee, S. F., Emmenegger, U., et al. (2026) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000786
Self-citation
Evaluating a Tailored Web-Based eHealth Intervention for Symptom Management in Couples Managing Prostate Cancer During the COVID-19 Pandemic: Randomized Clinical Trial
Song, L., Rini, C. K., Zhang, Y., Ma, C., Northouse, L., Nielsen, M. E., Tan, X., & Chen, R. C. (2026) · Journal of Medical Internet Research · doi:10.2196/88717
“Patients and partners separately reported their own QOL by completing the 27-item patient or partner version of the Functional Assessment of Chronic Illness Therapy-General (FACT-G) scale, respectively [19,20].”
Évaluation et modélisation de la qualité de vie des patients traités pour un cancer de la prostate.
Thanh, T. P. T. (2011) · doi:10.70675/70673d9dz9613z407fz9db3zcaee4c29a48c
A survivorship-oriented enhanced care model for patients undergoing radical prostatectomy
Yuan, X., Chen, Y., Lu, H., Zheng, P., Zhang, Y., Chen, M., & Sheng, X. (2026) · PLoS ONE · doi:10.1371/journal.pone.0346609
“The FACT-P demonstrated strong internal consistency and reliability in prostate cancer, with higher scores reflecting better quality of life[14].”
Standardized Program of Resistance Training for Prostate Cancer Patients Receiving Androgen Deprivation Therapy (SPoRT-PCa-ADT): study protocol for a randomized controlled trial
Soler-López, A., Gómez‐Carmona, C. D., González-Devesa, D., López-Plaza, D., Herrero-Vidal, L., Toledo-Pozuelo, R., González-Costea, A., & Avellaneda, E. C. (2026) · BMC Cancer · doi:10.1186/s12885-026-15902-w
“This instrument has been extensively validated in prostate cancer populations and demonstrates good sensitivity to change following interventions [41].”
Precision Oncology with 177 Lu-PSMA-617 Radionuclide Therapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer
Zhou, F., Zheng, Y., Huang, L., Tang, X., Yang, L., & Shao, S. (2026) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1177/10849785261447847
Muscle mitochondria, function, mass, and quality of life in prostate cancer during androgen deprivation therapy
Caeiro, L., Anderson, L. J., Dash, A., Marcinek, D. J., Kerr, H. L., Paulsen, L., Miranda, G., Jaramillo-Quiroz, S. D. C., Vaisar, T., Krueger, M. A., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73542-x
“ALM was a negative predictor of FACT-P PWB ( β = – 0.13, p 0.001) and PCa-speci ﬁ c concerns ( β = – 0.011, p = 0.005), as well as EORTC QLQ-C30 scores for SF ( β = – 0.02, p =0.023), and associated with worse fatigue ( β =0.05, p =0.014).”
Influential
Quantifying the short-term gains in health-related quality of life from androgen deprivation therapy in metastatic hormone-naïve prostate cancer
Nnabugwu, I. I., Nnabugwu, C. A., Obikeze, E., Anyimba, S. K., & Okoronkwo, I. (2026) · African Journal of Urology · doi:10.1186/s12301-026-00587-1
Identifying Distinct Quality-of-Life Profiles in Prostate Cancer Patients: A Latent Profile Approach
Cheng, L. (2026) · Current Oncology · doi:10.3390/curroncol33090532
“The validated Simplified Chinese version of the Functional Assessment of Cancer Therapy–Prostate (FACT-P), originally developed by Esper et al., was used to assess QoL [19].”
Carboplatin in patients with metastatic castration-resistant prostate cancer harboring somatic or germline homologous recombination repair gene mutations: phase II single-arm trial (CIPHER)
Jain, R. R., Vasudeva, N., Baskarane, H., Arora, A., Sharma, A., Kumar, A., Haresh, K. P., Kaushal, S., Shamim, S. A., Nayak, B., et al. (2026) · ESMO Open · doi:10.1016/j.esmoop.2026.108581
Cardiovascular Risk Triage Schema for Patients With Prostate Cancer Treated With Hormone Therapy
Guha, A., Barac, A., Ryan, M. J., Hamdan, R., Devgan, G., Marshall, C. H., Gillessen, S., Loeb, S., McKay, R. R., Antonarakis, E. S., et al. (2026) · JCO Oncology Practice · doi:10.1200/op-26-00312
Efficacy and Safety of Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Non-BRCA Mutation Subgroup of Patients with Metastatic Castration-resistant Prostate Cancer in the PROpel Trial
Mehra, N., Clarke, N. W., Armstrong, A. J., Oya, M., Shore, N. D., Procopio, G., Guedes, J. D., Arslan, Ç., Brown, E., Joung, J. Y., et al. (2026) · European Urology Oncology · doi:10.1016/j.euo.2026.08.014
Baseline Patient and Tumour Characteristics Associated with Mental Health in Men Undergoing Active Surveillance for Prostate Cancer
Russell, B. A., Tazi, M., Wylde, H., Francis, A., Pavlovich, C. P., Peacock, M., Nieboer, D., Venderbos, L. D. F., Prokar Dasgupta, A., & Hemelrijck, M. V. (2026) · BJUI Compass · doi:10.1002/bco2.70293
Within-patient changes in serum concentrations and patient-reported outcomes following symptom-guided enzalutamide dose reduction from 160 to 120 mg
Iguchi, T., Kato, M., Hirayama, Y., Yamasaki, T., Yasuda, S., Morita, N., Fukushima, W., Tamada, S., & Miyazawa, K. (2026) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2026.102702
The Psychological Well-Being of Men Diagnosed with Prostate Cancer
Walmsley, L. A. (2015) · UKnowledge (University of Kentucky)

Authors: Esper, P., Mo, F., Chodak, G., Sinner, M., Cella, D., & Pienta, K. J.
Affiliations: Rush University Medical Center (US)
Corresponding author: Esper, Peg
ORCID: Cella, David
Pienta, Kenneth J.
Venue: Urology
Publisher: Elsevier BV
Published: 1997-12
Volume: 50
Issue: 6
Pages: 920-928
ISSN: 0090-4295 (ISSN-L)
DOI: 10.1016/s0090-4295(97)00459-7
OpenAlex: W2004909463
Cited by: 696
References: 22
Citations by year: 2026: 18 · 2025: 22 · 2024: 34 · 2023: 25 · 2022: 45 · 2021: 34 · 2020: 20 · 2019: 31 · 2018: 35 · 2017: 29 · 2016: 33 · 2015: 30 · 2014: 28 · 2013: 31 · 2012: 27
FWCI: 4.00
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Urology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer survivorship and care
Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords: prostate cancer, quality of life, Functional Assessment of Cancer Therapy, questionnaire development, concurrent validity, internal consistency, sensitivity to change, prostate-specific antigen, performance status, disease stage
MeSH terms: Aged, Aged, 80 and over, Chicago, Humans, Male, Michigan, Middle Aged, Prostatic Neoplasms, Quality of Life, Surveys and Questionnaires, Sensitivity and Specificity, Reproducibility of Results

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-prostate instrument

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks